Sasa Radenkovic

Sasa Radenkovic

Auto-generated profile, based on publicly available information

Sasa Radenkovic

Medical Faculty, University of Nis, Blvd. Dr Zoran Djindjic 81, 18000 Nis, Serbia

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MGMilena Velojic Gubovic
Milena Velojic Gubovic
DDDragan Dimic
Dragan Dimic
SASlobodan Antic
Slobodan Antic
SRSasa Radenkovic
Sasa Radenkovic
BDBoris Djindjic
Boris Djindjic
MJMiodrag Jovanovic
Miodrag Jovanovic
Bacground/Aim. Visceral fat is highly active metabolic and endocrine tissue which secretes many adipokines that act both on local and systemic level. It is believed that adipokines and "low-grade inflammatory state" represent a potential link between obesity, metabolic syndrome, insulin resistance and cardiovascular disease. Leptin and adiponectin are considered to be the most important adipokines with the potential metabolic and cardiovascular effects. Body weight loss improves insulin sensitivity and decreases risk for most complications associated with obesity. The aim of this study was to determine the effects of moderate loss of body weight on the level of leptin and adiponectin, insulin sensitivity and abnormalities of glycoregulation in obese women, to determine whether and to what extent the secretory products of adipose tissue, leptin and adiponectin contribute to insulin sensitivity, as well as to assess their relationship and influence on glycemia and insulinemia during the period of losing body weight using a calorie restricted diet. Methods. The study involved 90 obese female subjects (BMI 􀂕 30 kg/m2) of different age with weight loss no less than 5% during a six-month period by application of restricted dietary regime. The calorie range was between 1,100-1,350 kcal. Serum levels of leptin and adiponectin, fasting glucose, fasting insulinemia, and Homeostasis Model Assessment of Insulin Resistance (HOMA-R) index were determined in all the subjects initially and after weight reduction. The presence of glycemic disorders was assessed on the basis of oral glucose tolerance test - OGTT. Results. Applying a 6-month restrictive dietary regime the subjects achieved an average weight loss of 8.73 ± 1.98 kg and 8.64 ± 1.96%, which led to the reduction of fasting glycemia, fasting insulinemia and HOMA-R index at the maximum level of statistical significance (p < 0.001). The achieved reduction led to a statistically significant decrease of leptin level and increase of adiponectin level (p < 0.001). The correction of the established pre-diabetic disorders of glycoregulation was not statistically significant. There was a statistically significant correlation between the anthropometric parameters, leptin, adiponectin, fasting glycemia, fasting insulinemia and HOMA-R index. There was a positive correlation between leptin, fasting insulinemia and HOMA-R, as well as a statistically significant negative correlation between adiponectin, fasting insulinemia and HOMA-R index (p < 0.01). Conclusion. Body weight increase and central fat accumulation lead to changes in serum levels of leptin and adiponectin, reduction of insulin sensitivity and development of glycemic dysregulation. Secretory products of adipose tissue, leptin and adiponectin contribute to the genesis of these disorders. The obtained results show that the effect of adiponectin on insulin sensitivity is more significant. The analysis of the effects of weight loss on the investigated parameters shows that moderate weight reduction by restrictive dietary regime lead to changes of investigated parameters at the maximum level of statistical significance. Such results emphasize the importance of weight reduction in obese persons, as well as the need for consistent implementation of restricted dietary regime in the process of treatment of obesity.

1 January 2009 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
MGMilena Velojic Gubovic
Milena Velojic Gubovic
DMD. Mikic
D. Mikic
Milica PešićMilica Pešić
Milica Pešić
DDD. Dimic
D. Dimic
SRS. Radenkovic
S. Radenkovic
SAS. Antic
S. Antic

1 March 2018 in Hormones
Verified
Journal Article
Closed access
PDF file
DRDanijela Radojkovic
Danijela Radojkovic
MPMilica Pesic
Milica Pesic
DDDragan Dimic
Dragan Dimic
TPTatjana Radjenovic Petkovic
Tatjana Radjenovic Petkovic
SRSasa Radenkovic
Sasa Radenkovic
MRMilan Radojkovic
Milan Radojkovic

1 January 2016 in Bratislava Medical Journal
Verified
Journal Article
Closed access
DDD. Dimic
D. Dimic
MGM. Velojic Golubovic
M. Velojic Golubovic
SRS. Radenkovic
S. Radenkovic
DRD. Radojkovic
D. Radojkovic
MPM. Pesic
M. Pesic
The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients

1 January 2007 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MPMilica Pesic
Milica Pesic
SASlobodan Antic
Slobodan Antic
RKRadivoj Kocic
Radivoj Kocic
DRDanijela Radojkovic
Danijela Radojkovic
SRSasa Radenkovic
Sasa Radenkovic
Background/Aims. Overt hypothyroidism is disease associated with accelerated arteriosclerosis and coronary heart disease. Whether subclinical hypothyroidism (SH) is associated with increased cardiovascular risk is contraversial. As SH is a high prevalence thyroid dysfunction, specially in older women, it is important to evaluate cardiovascular risk factors in these patients and that was the aim of this study. Methods. We examined 30 patients with SH and 20 healthy controls. Subclinical hypothireoidism was defined as an elevated thyrotropin (TSH) (> 4.5 mU/L) and normal free thyroxine (FT4) level. In all the participants we determined body mass index (BMI), blood pressure, TSH, FT4, antibodies to thyroid peroxidase, antibodies to thyroglobulin, total cholesterol, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, triglicerides, total cholesterol/HDL cholesterol ratio and LDL/HDL cholesterol ratio. Results. Mean BMI in patients with SH was significantly higher (p < 0.05), as well as diastolic blood pressure (p < 0.01) compared with the controls. Average levels of total cholesterol (5.40?0.62 vs 5.06?0.19 mmol/l, p < 0.01) and triglycerides (2.16?0.56 vs 1.89?0.24 mmol/l, p < 0.05) were also significantly higher in the group with SH. Individual analysis revealed that the percentage of patients with SH having borderline elevated total cholesterol (63.33%), hypertrigliceridemia (43.33%) and elevated total cholesterol/HDL cholesterol ratio (26.67%) were significantly higher than the percentage in the controls. No significant correlation between TSH and lipid parameters was detected. Conclusion. Subclinical hypothyroidism was associated with higher BMI, diastolic hypertension, higher total cholesterol and triglicerides levels and higher total cholesterol/HDL cholesterols ratio. This might increase the risk of accelerated arteriosclerosis in patients with SH.

1 January 2007 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MPMilica Pesic
Milica Pesic
SZSasa Zivic
Sasa Zivic
SRSasa Radenkovic
Sasa Radenkovic
MVMilena Velojic
Milena Velojic
DDDragan Dimic
Dragan Dimic
SASlobodan Antic
Slobodan Antic
Background/Aim. Insulin glargine is a long-acting insulin analog that mimics normal basal insulin secretion without pronounced peaks. The aim of this study was to compare insulin glargine with isophane insulin (NPH insulin) for basal insulin supply in patients with type 1 diabetes. Methods. A total of 48 type 1 diabetics on long term conventional intensive insulin therapy (IIT) were randomized to three different regimens of basal insulin substitution: 1. continuation of NPH insulin once daily at bedtime with more intensive selfmonitoring (n = 15); 2. NPH insulin twice daily (n = 15); 3. insulin glargine once daily (n = 18). Meal time insulin aspart was continued in all groups. Results. Fasting blood glucose (FBG) was lower in the glargine group (7.30?0.98 mmol/l) than in the twice daily NPH group (7.47?1.06 mmol/l), but without significant difference. FBG was significantly higher in the once daily NPH group (8.44?0.85 mmol/l; p < 0.05). HbA1c after 3 months did not change in the once daily NPH group, but decreased in the glargine group (from 7.72?0.86% to 6.87?0.50%), as well as in the twice daily NPH group (from 7.80?0.83% to 7.01?0.63%). Total daily insulin doses were similar in all groups but only in the glargine group there was an increase of basal and decrease of meal related insulin doses. The frequency of mild hypoglycemia was significantly lower in the glargine group (6.56?2.09) than in both NPH groups (9.0?1.65 in twice daily NPH group and 8.13?1.30 in other NPH group) (episodes/patients-month, p < 0.05). Conclusion. Basal insulin supplementation in type 1 diabetes mellitus with either twice daily NPH insulin or glargine can result in similar glycemic control when combined with meal time insulin aspart. However, with glargine regimen FBG, HbA1c and frequency of hypoglycemic event are lower. These facts contribute to better patients satisfaction with insulin glargine versus NPH insulin in IIT in type 1 diabetics.